rosiglitazone has been researched along with Nervous System Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, HG; Lin, YH; Lou, M; Sun, JZ; Wen, SQ; Zhang, FH | 1 |
| Jiao, Y; Tang, Z; Wang, L; Wu, G; Wu, J; Zhou, H | 1 |
2 other study(ies) available for rosiglitazone and Nervous System Disorders
| Article | Year |
|---|---|
Rosiglitazone attenuates hyperglycemia-enhanced hemorrhagic transformation after transient focal ischemia in rats.
Topics: Animals; Blood Glucose; Collagen Type IV; Glucose Transporter Type 1; Hemoglobins; Hyperglycemia; Hypoglycemic Agents; Immunohistochemistry; Infarction, Middle Cerebral Artery; Intracranial Hemorrhages; Ischemic Attack, Transient; Male; Nervous System Diseases; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones | 2013 |
Minimally invasive surgery for ICH evacuation followed by rosiglitazone infusion therapy increased perihematomal PPARĪ³ expression and improved neurological outcomes in rabbits.
Topics: Analysis of Variance; Animals; Blood-Brain Barrier; Cerebral Hemorrhage; Disease Models, Animal; Fibrinolytic Agents; Gene Expression Regulation; Male; Minimally Invasive Surgical Procedures; Nervous System Diseases; Permeability; PPAR gamma; Rabbits; Rosiglitazone; Thiazolidinediones; Tomography Scanners, X-Ray Computed | 2016 |